refrigerated cushion
Otherrefrigerated cushion
NCT Number: NCT02869867
Nursing study, prospective, randomized, two-center open-label.
Patients will be randomized into two groups during their first laying Qutenza®:
* Patients receiving the laying of Qutenza® without refrigerated cushion * Patients receiving the laying of Qutenza® associated with a refrigerated cushion
The objective of the study is to evaluate the effectiveness of the application of cold to the reduction of pain (burning) after one hour of patch installation high concentration capsaicin (Qutenza®) in patients localized neuropathic pain.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
CHLVO de Challans, Challans, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
refrigerated cushion
Time frame: after 1 hour of installation of Qutenza patch
Burning pain will be estimated by the patient using a non-graduated 10 cm line, presented horizontally to the patient with the extreme position of the vertical border on the left (0mm) representing the absence of perceived pain and the extreme position on the right (10 cm), the perception of the maximum pain that the patient can imagine. The information obtained is measured and translated into a score between 0 and 10.
The patient will be asked: "How would you rate the intensity of pain caused by Qutenza patch application?
Centre Hospitalier Departemental Vendee
Other
Acronym: DIDOCAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02763592
Allodynic Symptoms, Localized Neuropathic Pain
Clermont-Ferrand, France
View Trial Details